Deepthi Gunasekaran, MD
Assistant Professor of Medicine (Nephrology)
Research & Publications
Biography
News
Coauthors
Selected Publications
- How Sweet It Is: A Perspective on the Potential Anti-Tumor Role for SGLT2 InhibitorsGunasekaran D, Shirali A. How Sweet It Is: A Perspective on the Potential Anti-Tumor Role for SGLT2 Inhibitors. Kidney360 2023, 4: e1322-e1324. PMID: 37487034, PMCID: PMC10550005, DOI: 10.34067/kid.0000000000000219.
- Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the USPatidar K, Belcher J, Regner K, St. Hillien S, Simonetto D, Asrani S, Neyra J, Sharma P, Velez J, Wadei H, Nadim M, Chung R, Seethapathy R, Parada X, Ouyang T, Ufere N, Robinson J, Diaz P, Wilechansky R, Przybyszewski E, Smith T, Ali A, Orman E, Schulz P, Siddiqui S, Shabbir R, Liu L, Cama-Olivares A, Flannery A, Baker M, Gunasekaran D, Aswine A, Issa R, Li J, Verma S, Chalmers D, Varghese V, Lam W, Mohamed M, Kovacic R, Gaddy A, Attieh R, Cortes P, Semnani S, Wang L, Khemichian S, Allegretti A, consortium F. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. Journal Of Hepatology 2023, 79: 1408-1417. PMID: 37517455, PMCID: PMC10807505, DOI: 10.1016/j.jhep.2023.07.010.
- Walking the Line Between Antidonor and Antiviral Immunity: A Potential Role for BelataceptGunasekaran D, Pell J, Menon M. Walking the Line Between Antidonor and Antiviral Immunity: A Potential Role for Belatacept. Kidney International Reports 2022, 8: 1-3. PMID: 36644356, PMCID: PMC9832058, DOI: 10.1016/j.ekir.2022.11.005.
- Outcomes of Interventional Management of Coronary Artery Disease in Kidney Transplant Recipients.Chawla S, Lak HM, Sammour Y, Ahmed T, Gunasekaran D, Mutti J, Kaur M, Chahine J, Ellis S, Mansour J, Khatri J, Simpfendorfer C, Kapadia S. Outcomes of Interventional Management of Coronary Artery Disease in Kidney Transplant Recipients. Transplant Proc 2022, 54: 663-670. PMID: 35256200, DOI: 10.1016/j.transproceed.2022.02.006.